The Mectizan(® )Donation Program – highlights from 2005

Through the Mectizan(® )Donation Program, Merck & Co., Inc. has donated Mectizan (ivermectin, MSD) for the treatment of onchocerciasis worldwide since 1987. Mectizan has also been donated for the elimination of lymphatic filariasis (LF) since 1998 in African countries and in Yemen where onchocer...

Descripción completa

Detalles Bibliográficos
Autores principales: Alleman, Mary M, Twum-Danso, Nana AY, Thylefors, Björn I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618829/
https://www.ncbi.nlm.nih.gov/pubmed/17005039
http://dx.doi.org/10.1186/1475-2883-5-11

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1618829/
https://www.ncbi.nlm.nih.gov/pubmed/17005039
http://dx.doi.org/10.1186/1475-2883-5-11

Ejemplares similares